Adults with type 2 diabetes using a GLP-1 drug have a similar risk for thyroid cancer as those using other diabetes drugs, though increased thyroid cancer risk was observed in the first year after ...
The National Institutes of Health's reduction in research grants to 15% will disrupt vital medical research at UW-Madison, potentially delaying breakthroughs in cancer and Alzheimer's treatment.